Dechra Pharmaceuticals PLC Director/PDMR Shareholding (1005A)
March 21 2017 - 10:10AM
UK Regulatory
TIDMDPH
RNS Number : 1005A
Dechra Pharmaceuticals PLC
21 March 2017
21 March 2017
Dechra Pharmaceuticals PLC
(the Company)
Director Shareholding
Dechra Pharmaceuticals PLC has been notified that on 21 March
2017 Anthony Griffin, Executive Director, sold 3,500 ordinary
shares in the Company at a price of GBP16.76 each.
Following this acquisition, Anthony Griffin's beneficial
interest in the Company is 64,320 shares (0.069% of the current
issued share capital).
The Notification of Dealing Forms set out below are provided in
accordance with the requirements of the EU Market Abuse
Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial
Responsibility ("PDMR")/person closely
associated with them ("PCA")
--- -------------------------------------------------------------
a) Name Anthony Griffin
--- ------------------------------ -----------------------------
2. Reason for the notification
--- -------------------------------------------------------------
a) Position/status Director
--- ------------------------------ -----------------------------
b) Initial notification/ Initial Notification
amendment
--- ------------------------------ -----------------------------
3. Details of the Issuer
--- -------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--- ------------------------------ -----------------------------
b) LEI code N/A
--- ------------------------------ -----------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------
a) Description Ordinary Shares of 1 pence
of the financial each
instrument ISIN: GB0009633180
Identification
code
--- ------------------------------ -----------------------------
b) Nature of Sale of Shares
the transaction
--- ------------------------------ -----------------------------
c) Price(s) and Price(s) Volume(s)
volumes(s)
16.76 3,500
--- ------------------------------ ------------- --------------
d) Aggregated 3,500
information GBP16.76
* Aggregate volume GBP58,660.00
* Price
* Total
--- ------------------------------ -----------------------------
e) Date of the 2017.03.21
transaction
--- ------------------------------ -----------------------------
f) Place of the London Stock Exchange
transaction
--- ------------------------------ -----------------------------
For further information, please contact:
Suzana Cross, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHOKDDKQBKDFNB
(END) Dow Jones Newswires
March 21, 2017 10:10 ET (14:10 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2023 to Apr 2024